Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.

Report from Canada’s Drug Agency says Wegovy cuts risk of heart attack, stroke or cardiovascular death by 20 per cent ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

ABC News chief medical correspondent Dr. Tara Narula explains the findings of a new study on GLP-1 drugs commonly used for weight loss. Dr. Alexandra Sowa, an obesity medicine specialist and autho ...

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...